Phenome centre move ends GSK role


hammersmith hospital

The MRC-NIHR Phenome Centre will now be hosted at Imperial College’s Hammersmith Hospital, shown here © Imperial College London

Running costs have forced the national MRC-NIHR Phenome Centre to move from the Harlow labs of pharmaceutical company GlaxoSmithKline (GSK), where it was originally going to be sited. Instead, the centre emerging to exploit the NMR and LC–MS capabilities of the Olympic anti-doping labs is moving to a dedicated facility in Imperial College London’s Hammersmith Hospital. The centre’s initial proposal incorrectly assumed that using the GSK site would incur no space and infrastructure charges.

The move is costing Imperial £1 million and delaying the project by three months, but centre director Jeremy Nicholson, emphasises the new site is a better option. ‘The Olympic testing lab could not have been built without GSK and without that there wouldn’t have been a phenome centre,’ Nicholson adds. ‘We are grateful for that.’

‘We are proud to have played a part in the inception of the centre through the offer we made to provide this space,’ a GSK spokesperson says.


Related Content

Phenome Centre goes for gold

15 February 2013 Premium contentFeature

news image

Andy Extance finds out how British researchers are turning Olympic anti-doping facilities into a world-leading facility

Imperial launches second phenome centre

15 November 2012 News and Analysis

news image

New centre aims to improve diagnoses and inform doctors of the best treatments

Most Read

Not all science is created equal

16 October 2014 Comments

news image

John Ioannidis explains why researchers should be curious about the differences between disciplines

MDMA

9 October 2014 Podcast | Compounds

news image

The drug that fuelled rave culture may yet be a treatment for PTSD. Hayley Simon introduces MDMA

Most Commented

Helium happily shares electrons to create dianions

16 October 2014 Research

news image

Fullerene dianions created in nanodroplets of helium opening up new ways of creating exotic molecular species

Not all science is created equal

16 October 2014 Comments

news image

John Ioannidis explains why researchers should be curious about the differences between disciplines